Business
Director/PDMR Shareholding
Director/PDMR Shareholding.
About this update from Genedrive Plc
[{"type":"text","content":"\n\ngenedrive plc\n(\"genedrive\" or the \"Company\")\n \nDirector/PDMR Notification\n \ngenedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, makes the following announcement regarding a transaction in the Company's ordinary shares by Dr Ian Gilham, Non-Executive Chairman.\n \nNotification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.\n \n\n\n\n\n1. \n\n\nDetails of the person discharging managerial responsibilities / person closely associated\n\n\n\n\na. \n\n\nName\n\n\nDr Ian Gilham \n\n\n\n\n 2.\n\n\nReason for the notification\n\n\n\n\na. \n\n\nPosition/status\n\n\nNon-Executive Chairman\n\n\n\n\nb. \n\n\nInitial notification\n/Amendment\n\n\nInitial\n\n\n\n\n3. \n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n\n\n\n\na. \n\n\nName\n\n\ngenedrive plc\n\n\n\n\nb. \n\n\nLEI\n\n\n213800ZYODIRZ87Y4K14\n\n\n\n\n4. \n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n\n\n\n\na. \n\n\nDescription of the\nFinancial instrument, type\nof instrument\nIdentification code\n\n\nOrdinary Shares of 1.5p each\n \n \nGB00B1VKB244\n\n\n\n\nb. \n\n\nNature of the transaction\n\n\nPurchase of ordinary shares\n \n\n\n\n\nc. \n\n\nPrice(s) and volume(s)\n\n\n \n\n\n\n\nPrice(s)\n \n\n\nVolume(s)\n\n\n\n\n3.1p\n\n\n1,000,000\n \n\n\n\n\n\n\n\n\n\nd. \n\n\nAggregated information\n· Aggregated volume\n· ...